Pigs as xenogeneic donors

Transplantation Reviews

Volumn 19, Issue 3, 2005, Pages 164-177

  Yamada, Kazuhiko ^a   Griesemer, Adam ^a   Okumi, Masayoshi ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; CD40 LIGAND MONOCLONAL ANTIBODY; COMPLEMENT COMPONENT C3B RECEPTOR; CYCLOSPORIN A; PEPTIDE DERIVATIVE; PROTEIN ANTIBODY; SNAKE VENOM;

ACUTE GRAFT REJECTION; ARTICLE; CELL NUCLEUS TRANSPLANTATION; CHIMERA; CHRONIC GRAFT REJECTION; COMPLEMENT SYSTEM; CYTOTOXICITY; GENETIC ENGINEERING; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; INFECTION RISK; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LIVER TRANSPLANTATION; NONHUMAN; ORGAN DONOR; PATIENT SELECTION; POSTOPERATIVE INFECTION; PRIMATE; PROTEIN EXPRESSION; SWINE; THYMUS GRAFT; TRANSGENIC ANIMAL; TRANSPLANTATION TOLERANCE; VASCULARIZATION; XENOTRANSPLANTATION;

EID: 29444440888     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087200     Document Type: Article

References (118)

1. J.Y. Deschamps F.A. Roux P. Sai E. Gouin History of xenotransplantation Xenotransplantation 12 2005 91
2. K. Reemtsma B.H. McCracken J.U. Schlegel Renal heterotransplantation in man Ann Surg 160 1964 384
3. K. Reemtsma B.H. McCracken J.U. Schlegel M. Pearl Heterotransplantation of the kidney: Two clinical experiences Science 143 1964 700
4. C.N. Barnard The operation. A human cardiac transplant: An interim report of a successful operation performed at Groote Schuur Hospital, Cape Town S Afr Med J 41 1967 1271
5. L.L. Bailey S.L. Nehlsen-Cannarella W. Concepcion W.B. Jolley Baboon-to-human cardiac xenotransplantation in a neonate JAMA 254 1985 3321
6. T.E. Starzl J. Fung A. Tzakis et al. Baboon-to-human liver transplantation Lancet 341 1993 65
7. US guidelines on xenotransplantation Nat Med 5 1999 465 editorial
8. D.H. Sachs The pig as a potential xenograft donor Vet Immunol Immunopathol 43 1994 185
9. D.K. Cooper B. Gollackner D.H. Sachs Will the pig solve the transplantation backlog? Annu Rev Med 53 2002 133
10. K. Yamada K. Yazawa A. Shimizu et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue Nat Med 11 2005 32
11. D.H. Sachs MHC homozygous miniature swine In: M.M. Swindle D.C. Moody L.D. Phillips editors. Swine as models in biomedical research 1992 Iowa State University Press Ames (Iowa) 3
12. J.D. Mezrich G.W. Haller J.S. Arn S.L. Houser J.C. Madsen D.H. Sachs Histocompatible miniature swine: An inbred large-animal model Transplantation 75 2003 904
13. D.V. Cramer Natural antibodies and the host immune responses to xenografts Xenotransplantation 7 2000 83
14. D.K. Cooper A.H. Good E. Koren et al. Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: Relevance to discordant xenografting in man Transpl Immunol 1 1993 198
15. U. Galili M.R. Clark S.B. Shohet J. Buehler B.A. Macher Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1-3Gal epitope in primates Proc Natl Acad Sci U S A 84 1987 1369
16. U. Galili Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody Springer Semin Immunopathol 15 1993 155
17. U. Galili C.R. Gregory R.E. Morris New world monkeys as a primate model for xenografts in the absence of anti-Gal Transplant Proc 28 1996 567
18. U. Galili S.B. Shohet E. Kobrin C.L. Stults B.A. Macher Man, apes, and old world monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells J Biol Chem 263 1988 17755
19. U. Galili F. Anaraki A. Thall C. Hill-Black M. Radic One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody Blood 82 1993 2485
20. R. Buonomano C. Tinguely R. Rieben P.J. Mohacsi U.E. Nydegger Quantitation and characterization of anti-Galalpha1-3Gal antibodies in sera of 200 healthy persons Xenotransplantation 6 1999 173
21. I. Diaz P. Veira F. Valdes C. Alonso P. Sanchez Quantitation and comparison of anti-Gal-alpha-1,3-Gal antibodies in sera of healthy individuals and patients waiting for kidney transplantation Transplant Proc 35 2003 2043
22. F.H. Bach S.C. Robson H. Winkler et al. Barriers to xenotransplantation Nat Med 1 1995 869
23. T. Kobayashi S. Taniguchi F.A. Neethling et al. Delayed xenograft resection of pig-to-baboon cardiac transplants after cobra venom factor therapy Transplantation 64 1997 1255
24. M. Chrupcala S. Pomer G. Staehler R. Waldherr C. Kirschfink Prolongation of discordant renal xenograft survival by depletion of complement. Comparative effects of systemically administered cobra venom factor and soluble complement receptor type 1 in a guinea-pig to rat model Transpl Int 7 Suppl 1 1994 S650
25. M. Chrupcala S. Pomer R. Waldherr G. Staehler M. Kirschfink Effect of complement modulation with the soluble complement receptor sCR1 on survival and function of kidney xenotransplant. An experimental study with a new guinea pig to rate transplant model Urologe A 35 1996 478
26. B. Heckl-Ostreicher A. Wosnik M. Kirschfink Protection of porcine endothelial cells from complement-mediated cytotoxicity by the human complement regulators CD59, C1 inhibitor, and soluble complement receptor type 1-analysis in a pig-to-human in vitro model relevant to hyperacute xenograft rejection Transplantation 62 1996 1693
27. M. Basker L. Buhler I.P. Alwayn J.Z. Appel III D.K. Cooper Pharmacotherapeutic agents in xenotransplantation Expert Opin Pharmacother 1 2000 757
28. Y. Lin M.P. Soares K. Sato et al. Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts J Immunol 163 1999 2850
29. E. Cozzi D.J. White The generation of transgenic pigs as potential organ donors for humans Nat Med 1 1995 964
30. T.E. Mollnes A.E. Fiane Perspectives on complement in xenotransplantation Mol Immunol 40 2003 135
31. D.H. Adams A. Kadner R.H. Chen R.S. Farivar Human membrane cofactor protein (MCP, CD 46) protects transgenic pig hearts from hyperacute rejection in primates Xenotransplantation 8 2001 36
32. S.L. Houser K. Kuwaki C. Knosalla et al. Thrombotic microangiopathy and graft arteriopathy in pig hearts after transplantation into baboons Xenotransplantation 11 2004 416
33. C.G. McGregor S.S. Teotia G.W. Byrne et al. Cardiac xenotransplantation: progress toward the clinic Transplantation 78 2004 1569
34. R. Manez E. Lopez-Pelaez A. Centeno Transgenic expression in pig hearts of both human decay-accelerating factor and human membrane cofactor protein does not provide an additional benefit to that of human decay-accelerating factor alone in pig-to-baboon xenotransplantation Transplantation 78 2004 930
35. R. Zhong Y. Luo H. Yang et al. Improvement in human decay accelerating factor transgenic porcine kidney xenograft rejection with intravenous administration of gas914, a polymeric form of alphaGAL Transplantation 75 2003 10
36. B. Garcia H.T. Sun H.J. Yang G. Chen R. Zhong Xenotransplantation of human decay accelerating factor transgenic porcine kidney to non-human primates: 4 years experience at a Canadian center Transplant Proc 36 2004 1714
37. L. Buhler K. Yamada H. Kitamura et al. Pig kidney transplantation in baboons: Anti-Gal(alpha)1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation Transplantation 72 2001 1743
38. R.N. Barth S. Yamamoto J.C. LaMattina et al. Xenogeneic thymokidney and thymic tissue transplantation in a pig-to-baboon model: I. Evidence for pig-specific T-cell unresponsiveness Transplantation 75 2003 1615
39. G.P.J. Alexandre P. Gianello D. Latinne et al. Plasmapheresis and splenectomy in experimental renal xenotransplantation In: M.A. Hardy editor. Xenograft 25 1989 Excerpta Medica New York 259
40. I.P. Alwayn M. Basker L. Buhler D.K. Cooper The problem of anti-pig antibodies in pig-to-primate xenografting: Current and novel methods of depletion and/or suppression of production of anti-pig antibodies Xenotransplantation 6 1999 157
41. S. Taniguchi F.A. Neethling E.Y. Korchagina et al. In vivo immunoadsorption of antipig antibodies in baboons using a specific Gal(alpha)1-3Gal column Transplantation 62 1996 1379
42. A. Watts A. Foley M. Awwad et al. Plasma perfusion by apheresis through a Gal immunoaffinity column successfully depletes anti-Gal antibody: experience with 320 aphereses in baboons Xenotransplantation 7 2000 181
43. K. Kuwaki C. Knosalla K. Moran et al. Reduction of anti-Galalpha1,3Gal antibodies by infusion of types 2 and 6 gal trisaccharides conjugated to poly-L-lysine Xenotransplantation 11 2004 210
44. T. Kozlowski R. Monroy Y. Xu et al. Anti-α Gal antibody response to porcine bone marrow in unmodified baboons and baboons conditioned for tolerance induction Transplantation 66 1998 176
45. K. Kuwaki C. Knosalla F.J. Dor et al. Suppression of natural and elicited antibodies in pig-to-baboon heart transplantation using a human anti-human CD154 mAb-based regimen Am J Transplant 4 2004 363
46. M.P. Soares Y. Lin K. Sato K.M. Stuhlmeier F.H. Bach Accommodation Immunol Today 20 1999 434
47. G.P. Alexandre J.P. Squifflet M. De Bruyere et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts Transplant Proc 19 1987 4538
48. K. Takahashi K. Saito S. Takahara et al. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan Am J Transplant 4 2004 1089
49. D.S. Warren A.A. Zachary C.J. Sonnenday et al. Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers Am J Transplant 4 2004 561
50. J.L. Platt The immunological barriers to xenotransplantation Crit Rev Immunol 16 1996 331
51. M.S. Sandrin N. Osman I.F. McKenzie Transgenic approaches for the reduction of Galalpha(1,3)Gal for xenotransplantation Front Biosci 2 1997 e1
52. M.S. Sandrin W.L. Fodor E. Mouhtouris et al. Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis Nat Med 1 1995 1261
53. C.J. Phelps C. Koike T.D. Vaught Production of alpha 1,3-galactosyltransferase-deficient pigs Science 299 2003 411
54. D. Kolber-Simonds L. Lai S.R. Watt et al. Production of {alpha}-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations Proc Natl Acad Sci U S A 101 2004 7335
55. L. Lai D. Kolber-Simonds K. Park et al. Production of -1,3-Galactosyltransferase knockout pigs by nuclear transfer cloning Science 295 2002 1089
56. F.J. Dor Y.L. Tseng J. Cheng et al. Valpha1,3-Galactosyltransferase gene-knockout miniature swine produce natural cytotoxic anti-Gal antibodies Transplantation 78 2004 15
57. K. Kuwaki Y.L. Tseng F.J. Dor et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience Nat Med 11 2005 29
58. B. Gollackner S.K. Goh I. Qawi et al. Acute vascular rejection of xenografts: Roles of natural and elicited xenoreactive antibodies in activation of vascular endothelial cells and induction of procoagulant activity Transplantation 77 2004 1735
59. B. Samstein J.L. Platt Physiologic and immunologic hurdles to xenotransplantation J Am Soc Nephrol 12 2001 182
60. N. Cretin J. Bracy K. Hanson J. Iacomini The role of T cell help in the production of antibodies specific for Gal alpha 1-3Gal J Immunol 168 2002 1479
61. L. Buhler I.P. Alwayn M. Basker et al. CD40-CD154 pathway blockade requires host macrophages to induce humoral unresponsiveness to pig hematopoietic cells in baboons Transplantation 72 2001 1759
62. M. Usuda K. Fujimori N. Koyamada et al. Successful use of anti-CD20 monoclonal antibody (rituximab) for ABO-incompatible living-related liver transplantation Transplantation 79 2005 12
63. T. Sawada S. Fuchinoue S. Teraoka Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis Transplantation 74 2002 1207
64. D. Yin H. Zeng L. Ma et al. Cutting edge: NK cells mediate IgG1-dependent hyperacute rejection of xenografts J Immunol 172 2004 7235
65. J.D. Seebach K. Yamada I.M. McMorrow D.H. Sachs H. DerSimonian Xenogeneic human anti-pig cytotoxicity mediated by activated natural killer cells Xenotransplantation 3 1996 188
66. B.C. Baumann M.K. Schneider B.G. Lilienfeld et al. Endothelial cells derived from pigs lacking Gal alpha(1,3)Gal: No reduction of human leukocyte adhesion and natural killer cell cytotoxicity Transplantation 79 2005 1067
67. C. Costa D.F. Barber W.L. Fodor Human NK cell-mediated cytotoxicity triggered by CD86 and Gal alpha 1,3-Gal is inhibited in genetically modified porcine cells J Immunol 168 2002 3808
68. + helper T cells and self antigen-presenting cells in the mouse J Exp Med 172 1990 567
69. K. Yamada D.H. Sachs H. DerSimonian Human anti-porcine xenogeneic T-cell response. Evidence for allelic specificity of MLR and for both direct and indirect pathways of recognition J Immunol 155 1995 5249
70. A.G. Murray M.M. Khodadoust J.S. Pober A.L. Bothwell Porcine aortic endothelial cells activate human T cells: Direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28 Immunity 1 1994 57
71. R.J. Baker M.P. Hernandez-Fuentes P.A. Brookes A.N. Chaudhry H.T. Cook R.I. Lechler Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: Implications for the pathogenesis of chronic allograft nephropathy J Immunol 167 2001 7199
72. A. Chandraker M.E. Russell T. Glysing-Jensen R.A. Willett M.H. Sayegh T-cell costimulatory blockade in experimental chronic cardiac allograft rejection - effects of cyclosporine and donor antigen Transplantation 63 1997 1053
73. R.B. Colvin C.M. Chase H.J. Winn P.S. Russell Chronic allograft arteriopathy: Insights from experimental models In: C.G. Orosz D.D. Sedmak R.M. Ferguson editors. Transplant Vascular Sclerosis 1995 RG Landes Austin, TX 7-34
74. P. Hayry H. Isoniemi S. Yilmaz et al. Chronic allograft rejection Immunol Rev 134 1993 33
75. P.I. Hornick P.D. Mason R.J. Baker et al. Significant frequencies of T cells with indirect anti-donor specificity in heart graft recipients with chronic rejection Circulation 101 2000 2405
76. K.L. Womer J.R. Stone B. Murphy A. Chandraker M.H. Sayegh Indirect allorecognition of donor class I and II major histocompatibility complex peptides promotes the development of transplant vasculopathy J Am Soc Nephrol 12 2001 2500
77. P.S. Russell C.M. Chase H.J. Winn R.B. Colvin Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity J Immunol 152 1994 5135
78. P.S. Russell C.M. Chase R.B. Colvin Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: Lack of progression to sclerotic lesions in B cell-deficient mice Transplantation 64 1997 1531
79. P.S. Russell C.M. Chase M. Sykes H. Ito J. Shaffer R.B. Colvin Tolerance, mixed chimerism, and chronic transplant arteriopathy J Immunol 167 2001 5731
80. H. Azuma A. Chandraker K. Nadeau et al. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection Proc Natl Acad Sci U S A 93 1996 12439
81. U.W. Heemann H. Azuma S.G. Tullius H. Mackenzie B.M. Brenner N.L. Tilney The contribution of reduced functioning mass to chronic kidney allograft dysfunction in rats Transplantation 58 1994 1317
82. S.G. Tullius N.L. Tilney Both alloantigen-dependent and -independent factors influence chronic allograft rejection Transplantation 59 1995 313
83. J. Pratschke M.J. Wilhelm I. Laskowski et al. Influence of donor brain death on chronic rejection of renal transplants in rats J Am Soc Nephrol 12 2001 2474
84. M. Sykes Mixed chimerism and transplant tolerance Immunity 14 2001 417
85. T. Wekerle M.H. Sayegh J. Hill et al. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance J Exp Med 187 1998 2037
86. H. Ohdan Y.G. Yang A. Shimizu K.G. Swenson M. Sykes Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3Gal-mediated graft rejection J Clin Invest 104 1999 281
87. H. Ohdan Y.G. Yang K.G. Swenson H. Kitamura M. Sykes T cell and B cell tolerance to GALalpha1,3GAL-expressing heart xenografts is achieved in alpha1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism Transplantation 71 2001 1532
88. T. Sablinski D.W. Emery R. Monroy et al. Long-term discordant xenogeneic (porcine-to-primate) bone marrow engraftment in a monkey treated with porcine-specific growth factors Transplantation 67 1999 972
89. T. Kozlowski R. Monroy M. Giovino et al. Effect of pig-specific cytokines on mobilization of hematopoietic progenitor cells in pigs and on pig bone marrow engraftment in baboons Xenotransplantation 6 1999 17
90. K. Nash Q. Chang A. Watts et al. Peripheral blood progenitor cell mobilization and leukapheresis in pigs Lab Anim Sci 49 1999 645
91. L. Buhler C. Goepfert H. Kitamura et al. Porcine hematopoietic cell xenotransplantation in nonhuman primate is complicated by a thrombotic microangiopathy Bone Marrow Transplant 27 2001 1227
92. I.P.J. Alwayn L. Buhler J.Z. Appel et al. Mechanisms of thrombotic microangiopathy following xenogeneic hematopoietic progenitor cell transplantation Transplantation 71 2001 1601
93. L. Buhler M. Awwad S. Treter et al. Pig hematopoietic cell chimerism in baboons conditioned with a nonmyeloablative regimen and CD154 blockade Transplantation 73 2002 12
94. L. Buhler M. Awwad M. Basker et al. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response Transplantation 69 2000 2296
95. - porcine hematopoietic cells on primate platelet aggregation and endothelial cell activation: implications for the induction of mixed hematopoietic chimerism in the pig-to-primate model Xenotransplantation 11 2004 72
96. Y.L. Tseng F.J. Dor K. Kuwaki et al. vBone marrow transplantation from alpha1,3-galactosyltransferase gene-knockout pigs in baboons Xenotransplantation 11 2004 361
97. Y. Zhao K. Swenson J.J. Sergio J.S. Arn D.H. Sachs M. Sykes Skin graft tolerance across a discordant xenogeneic barrier Nat Med 2 1996 1211
98. J.I. Rodriguez-Barbosa Y. Zhao R. Barth et al. Enhanced CD4 reconstitution by grafting neonatal porcine tissue in alternative locations is associated with donor-specific tolerance and suppression of preexisting xenoreactive T cells Transplantation 72 2001 1223
99. B. Nikolic J.P. Gardner D.T. Scadden J.S. Arn D.H. Sachs M. Sykes Normal development in porcine thymus grafts and specific tolerance of human T cells to porcine donor MHC J Immunol 162 1999 3402
100. G.W. Haller N. Esnaola K. Yamada et al. Thymic transplantation across an MHC class I barrier in swine J Immunol 163 1999 3785
101. J.C. LaMattina N. Kumagai R.N. Barth et al. Vascularized thymic lobe transplantation in miniature swine: I. Vascularized thymic lobe allografts support thymopoiesis Transplantation 73 2002 826
102. K. Yamada A. Shimizu F.L. Ierino Thymic transplantation in miniature swine. I. Development and function of the "thymokidney" Transplantation 68 1999 1684
103. K. Yamada A. Shimizu R. Utsugi et al. Thymic transplantation in miniature swine. II. Induction of tolerance by transplantation of composite thymokidneys to thymectomized recipients J Immunol 164 2000 3079
104. K. Yamada P.A. Vagefi R. Utsugi et al. Thymic transplantation in miniature swine: III. Induction of tolerance by transplantation of composite thymokidneys across fully major histocompatibility complex-mismatched barriers Transplantation 76 2003 530
105. C. Kamano P.A. Vagefi N. Kumagai et al. Vascularized thymic lobe transplantation in miniature swine: Thymopoiesis and tolerance induction across fully MHC-mismatched barriers Proc Natl Acad Sci U S A 101 2004 3827
106. R.N. Pierson 3rd Xenotransplantation at the crossroads [commentary] Xenotransplantation 11 2004 391
107. N.J. Mueller R.N. Barth S. Yamamoto et al. Activation of cytomegalovirus in pig-to-primate organ xenotransplantation J Virol 76 2002 4734
108. S.S. Lin J.L. Platt Genetic therapies for xenotransplantation J Am Coll Surg 186 1998 388
109. Platt JL. Xenotransplantation. New risks, new gains. Nature 2000;407:27-29.
110. C. Patience Y. Takeuchi R.A. Weiss Zoonosis in xenotransplantation Curr Opin Immunol 10 1998 539
111. P. Ramirez R. Chavez M. Majado et al. Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days Transplantation 70 2000 989
112. E.A. Rose A.C. Gelijns A.J. Moskowitz et al. Long-term mechanical left ventricular assistance for end-stage heart failure N Engl J Med 345 2001 1435
113. J.A. Fishman C. Patience Xenotransplantation: Infectious risk revisited Am J Transplant 4 2004 1383
114. C. Patience Y. Takeuchi R.A. Weiss Infection of human cells by an endogenous retrovirus of pigs Nat Med 3 1997 282
115. B.A. Oldmixon J.C. Wood T.A. Ericsson et al. Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine J Virol 76 2002 3045
116. M. Wilhelm J.A. Fishman R. Pontikis A.M. Aubertin F.X. Wilhelm Susceptibility of recombinant porcine endogenous retrovirus reverse transcriptase to nucleoside and non-nucleoside inhibitors Cell Mol Life Sci 59 2002 2184
117. N.J. Mueller K. Kuwaki F.J. Dor et al. Reduction of consumptive coagulopathy using porcine cytomegalovirus-free cardiac porcine grafts in pig-to-primate xenotransplantation Transplantation 78 2004 1449
118. C.A. Huang Y. Fuchimoto Z.L. Gleit et al. Posttransplant lymphoproliferative disease in miniature swine after allogeneic hematopoietic cell transplantation: Similarity to human PTLD and association with a porcine gammaherpesvirus Blood 97 2001 1467